#Revasc - Twitter Hashtag

29 days ago

In TAVI patients with CAD, how much myocardium you leave at risk really matters. REVASC-TAVI: 30 centers, 2,400+ patients across 4 continents Huge thanks to @BURZOTTA_F , @MarcoBarbanti, @GiulianoCosta & to all #REVASC-TAVI investigators https://t.co/mKqCRhyNQr

0

7

2

1

233

JACC Journals @JACCJournals

about 2 months ago

5-year FAME 3: FFR-guided #PCI w/ zotarolimus DES for multivessel CAD had 30% lower cost, similar QALYs, & faster early #QoL recovery vs CABG, reinforcing value & patient-centered #revasc decisions. https://t.co/oholbzhSAc 🧵 (n/7) #JACC #cvCAD #cvCABG

JACCJournals's tweet photo. 5-year FAME 3: FFR-guided #PCI w/ zotarolimus DES for multivessel CAD had 30% lower cost, similar QALYs, & faster early #QoL recovery vs CABG, reinforcing value & patient-centered #revasc decisions. https://t.co/oholbzhSAc

🧵 (n/7) #JACC #cvCAD #cvCABG https://t.co/Z1GUA3KE5E

3

24

10

8

9K

JACC Journals @JACCJournals

about 2 months ago

Refractory RISR may reflect an underrecognized inflammatory vascular process, not just mechanical failure. In select pts after failed #revasc, systemic anti-inflammatory therapy could be a viable alternative. https://t.co/qgPS5QupAw #JACCCaseReports

$JACCJournals's tweet photo. Refractory RISR may reflect an underrecognized inflammatory vascular process, not just mechanical failure. In select pts after failed #revasc, systemic anti-inflammatory therapy could be a viable alternative. https://t.co/qgPS5QupAw #JACCCaseReports https://t.co/ppstiLaTgC$

0

12

2

0

2K

JACC Journals @JACCJournals

2 months ago

Guiding #revascularization decisions in ischemic cardiomyopathy? Study demonstrated that patient-specific anatomic reporting of vascular jeopardy & viability by cath & #WhyCMR identifies pts who experience mortality benefit from #revasc https://t.co/IHzX8JO84O #JACCIMG #whyCMR

JACCJournals's tweet photo. Guiding #revascularization decisions in ischemic cardiomyopathy? Study demonstrated that patient-specific anatomic reporting of vascular jeopardy & viability by cath & #WhyCMR identifies pts who experience mortality benefit from #revasc https://t.co/IHzX8JO84O #JACCIMG #whyCMR https://t.co/ouFmGBB9sf

2

27

11

12

4K

American College of Cardiology @ACCinTouch

5 months ago

Patient-specific registration of segmental jeopardy and viability is a feasible strategy to identify patients with ischemic cardiomyopathy who benefit from early #revasc, according to a recent study published in #JACCIMG. Get more details ➡️ https://t.co/pdbuiHuAPf @JACCJournals

ACCinTouch's tweet photo. Patient-specific registration of segmental jeopardy and viability is a feasible strategy to identify patients with ischemic cardiomyopathy who benefit from early #revasc, according to a recent study published in #JACCIMG.

Get more details ➡️ https://t.co/pdbuiHuAPf @JACCJournals https://t.co/vkEGhVNju7

0

30

4

8

3K

JACC Journals @JACCJournals

6 months ago

Kidney function remains a strong prognostic factor in older MI pts. Physiology-guided complete #revasc is effective regardless of renal function & may provide greater absolute clinical benefit in pts w/ #CKD due to their elevated baseline risk. https://t.co/fhxK9kDZkk #JACCINT

JACCJournals's tweet photo. Kidney function remains a strong prognostic factor in older MI pts. Physiology-guided complete #revasc is effective regardless of renal function & may provide greater absolute clinical benefit in pts w/ #CKD due to their elevated baseline risk. https://t.co/fhxK9kDZkk #JACCINT https://t.co/lzKJ0ghcFO

0

35

7

6

4K

JACC Journals @JACCJournals

8 months ago

In the randomized PROCTOR trial, SVG #PCI was assoc w/ improved 1-yr clinical outcomes compared w/ native vessel PCI, primarily driven by lower rates of PCI-related MI & clinically driven target coronary territory #revasc. https://t.co/hKqzxAFNHq #TCT2025 #JACC #cvMI #cvCABG

JACCJournals's tweet photo. In the randomized PROCTOR trial, SVG #PCI was assoc w/ improved 1-yr clinical outcomes compared w/ native vessel PCI, primarily driven by lower rates of PCI-related MI & clinically driven target coronary territory #revasc. https://t.co/hKqzxAFNHq

#TCT2025 #JACC #cvMI #cvCABG https://t.co/17qF7LLoH4

1

137

50

37

17K

JACC Journals @JACCJournals

about 1 year ago

In this SWEDEHEART registry analysis of #STEMI w/ multivessel disease, complete #revasc, whether angio or physiology-guided, was independently associated with better outcomes, including mortality. https://t.co/psA01ksCkh @ColinBerryMD #Revascularization #CardioX #JACCINT

JACCJournals's tweet photo. In this SWEDEHEART registry analysis of #STEMI w/ multivessel disease, complete #revasc, whether angio or physiology-guided, was independently associated with better outcomes, including mortality. https://t.co/psA01ksCkh

@ColinBerryMD #Revascularization #CardioX #JACCINT https://t.co/j8KwSw6b6X

0

26

6

5

6K

JACC Journals @JACCJournals

about 1 year ago

In this #SWEDEHEART registry analysis of #STEMI w/ multivessel disease, complete #revasc, whether angio or physiology-guided, was independently associated with better outcomes, including mortality. https://t.co/psA01ksCkh #JACCINT #Revascularization #CardioX @ColinBerryMD

1

34

10

9

5K

JACC Journals @JACCJournals

about 1 year ago

Significant demographic, stress testing, #revasc & survival differences were found between Black & White pts, even when matched for demographic & clinical characteristics. Strategies to enhance equity in CV care remain crucial in #cvImaging https://t.co/5yPaLHe3mH #JACCIMG #cvCAD

JACCJournals's tweet photo. Significant demographic, stress testing, #revasc & survival differences were found between Black & White pts, even when matched for demographic & clinical characteristics. Strategies to enhance equity in CV care remain crucial in #cvImaging https://t.co/5yPaLHe3mH #JACCIMG #cvCAD https://t.co/6e1HS5ehmd

1

12

4

0

3K

JACC Journals @JACCJournals

about 1 year ago

Is it time to move beyond TIMI 3 flow as a prognostic marker in primary #PCI? Could CK-MB kinetics offer a more reliable alternative? Check out this insightful #JACCAsia editorial exploring this shift in CV risk assessment! 🫀📉 https://t.co/GrXzUogkVs #cvAMI #Revasc

0

13

2

1

4K

JACC Journals @JACCJournals

about 1 year ago

Chronic stent recoil occurred in 1 of 5 lesions treated with second- or newer-generation #DES requiring repeat #revasc, with severe calcium and nonuniform stent expansion identified as risk factors, and was associated with TLR. https://t.co/aPfdcGclCB #JACCINT #OCT

JACCJournals's tweet photo. Chronic stent recoil occurred in 1 of 5 lesions treated with second- or newer-generation #DES requiring repeat #revasc, with severe calcium and nonuniform stent expansion identified as risk factors, and was associated with TLR. https://t.co/aPfdcGclCB #JACCINT #OCT https://t.co/GqRERO1KG4

1

119

39

41

30K

JACC Journals @JACCJournals

about 1 year ago

Prolonged balloon-to-peak CK-MB (BP-time) in AMI patients post-primary PCI was found independently associated to ⬆️ 1-year CV mortality. 🤔 Can BP-time emerge as s new tool for early risk stratification? https://t.co/bVSbjl06UP #JACCAsia #PCI #cvAMI #Revasc

JACCJournals's tweet photo. Prolonged balloon-to-peak CK-MB (BP-time) in AMI patients post-primary PCI was found independently associated to ⬆️ 1-year CV mortality.

🤔 Can BP-time emerge as s new tool for early risk stratification? https://t.co/bVSbjl06UP

#JACCAsia #PCI #cvAMI #Revasc https://t.co/ybfOq5Fmzz

0

31

7

8

4K

American College of Cardiology @ACCinTouch

about 1 year ago

Randomized data suggest that supervised exercise therapy can improve pain and maximal walking distance as initial treatment and in addition to #revasc in patients with #cvPAD and claudication symptoms. Read more: https://t.co/YUDP0TdYt4

ACCinTouch's tweet photo. Randomized data suggest that supervised exercise therapy can improve pain and maximal walking distance as initial treatment and in addition to #revasc in patients with #cvPAD and claudication symptoms.

Read more: https://t.co/YUDP0TdYt4 https://t.co/8idPlFsLSR

0

23

10

6

4K

JACC Journals @JACCJournals

about 1 year ago

#JACCAsia EiC Dr. Jianan Wang: In pts w/ non-complex #cvCAD, AngioFFR-guided comprehensive #PCI strategy, including PCI decision-making & stent optimization, was non-inferior to #IVUS-guided strategy for the composite endpoint of death, #cvMI, or #revasc at 12 months #ACC25

JACCJournals's tweet photo. #JACCAsia EiC Dr. Jianan Wang: In pts w/ non-complex #cvCAD, AngioFFR-guided comprehensive #PCI strategy, including PCI decision-making & stent optimization, was non-inferior to #IVUS-guided strategy for the composite endpoint of death, #cvMI, or #revasc at 12 months #ACC25 https://t.co/v0CEgsZvy9

0

8

0

1

2K

Jose M Martínez-Comendador @JMMComendador

over 1 year ago

📌 CABG vs. PCI in ECMO patients 🔍 Retrospective study on revascularization strategies in patients on circulatory support. 🫀 Surgery or percutaneous intervention? Find out here: https://t.co/ZhjgBXA3j4 👉 [Link to the article] https://t.co/kwuWhII0Oe #ECMO #Revasc #SECCE

0

3

1

165

JACC Journals @JACCJournals

over 1 year ago

Fem-pop revascularizations: Undergoing a substantial decline? See the trends: https://t.co/m1TKc3GSG8 #JACC #Revascularization #Revasc @rwyeh @JMKimMD

JACCJournals's tweet photo. Fem-pop revascularizations: Undergoing a substantial decline? See the trends: https://t.co/m1TKc3GSG8

#JACC #Revascularization #Revasc @rwyeh @JMKimMD https://t.co/J0CQyiIoVD

0

10

3

1

9K

IllinoisACC @IllinoisACC

over 1 year ago

In this #EaglesEyeView, Dr. @keaglemd discusses: ⭐ Transseptal Mitral Valve-in-Valve Procedure ⭐ Complete vs. Culprit-Only #Revasc in Older Patients ⭐ Hypertensive #Pregnancy & #cvMI Risk 🎧 Tune in here: https://t.co/ekW5xsW9J6

IllinoisACC's tweet photo. In this #EaglesEyeView, Dr. @keaglemd discusses:
⭐ Transseptal Mitral Valve-in-Valve Procedure
⭐ Complete vs. Culprit-Only #Revasc in Older Patients
⭐ Hypertensive #Pregnancy & #cvMI Risk

🎧 Tune in here: https://t.co/ekW5xsW9J6 https://t.co/mCkDmqtPae

0

4

1

0

374

Missouri ACC @MissouriACC

over 1 year ago

In this #EaglesEyeView, Dr. @keaglemd discusses: ⭐ Transseptal Mitral Valve-in-Valve Procedure ⭐ Complete vs. Culprit-Only #Revasc in Older Patients ⭐ Hypertensive #Pregnancy & #cvMI Risk 🎧 Tune in here: https://t.co/3hhC9K6qLu

MissouriACC's tweet photo. In this #EaglesEyeView, Dr. @keaglemd discusses:
⭐ Transseptal Mitral Valve-in-Valve Procedure
⭐ Complete vs. Culprit-Only #Revasc in Older Patients
⭐ Hypertensive #Pregnancy & #cvMI Risk

🎧 Tune in here: https://t.co/3hhC9K6qLu https://t.co/ybDJWYvxtH

0

7

3

0

892

American College of Cardiology @ACCinTouch

over 1 year ago

Q. Is revascularization beneficial for patients presenting w/ #cvACS & at ⬆️ risk for frailty? A. #Revasc is associated w/ short- & long-term CV benefits in patients at intermediate & high risk of frailty. Read the journal scan to learn more: https://t.co/UuJeTWbobK #cvSurg

1

7

6

2

3K

Top Tweets for #Revasc

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users